Rein Therapeutics (RNTX) Treasury Shares (2016 - 2026)
Rein Therapeutics (RNTX) posted quarterly Treasury Shares of $314006.0 for Q1 2026, little changed year-over-year from $314006.0 in Q1 2025, and up 2467.09% quarter-over-quarter from $12232.0 in Q4 2025.
Rein Therapeutics (RNTX) Treasury Shares (2016 - 2026) Analysis & Trends
Rein Therapeutics (RNTX) has reported Treasury Shares for 10 consecutive years, with $314006.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $314006.0; the TTM figure through Mar 2026 stood at $314006.0 (changed 0.0% YoY), while the FY2025 annual figure was $314006.0, changed 0.0% from the prior year.
- Treasury Shares improved to $314006.0 in Q1 2026 per RNTX's latest filing, from $12232.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $6.3 million in Q1 2022 and bottomed at $12232.0 in Q4 2024.
- Historically, Treasury Shares has averaged $1.4 million across 5 years, with a median of $314006.0 in 2023.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 2412.05% — and 2023, when it plunged 95.0%.
- Rein Therapeutics' Treasury Shares stood at $6.3 million in 2022, then plunged by 99.61% to $24610.0 in 2023, then sank by 50.3% to $12232.0 in 2024, then changed by 0.0% to $12232.0 in 2025, then surged by 2467.09% to $314006.0 in 2026.
- Business Quant data shows RNTX's Treasury Shares at $314006.0 in Q1 2026, $12232.0 in Q4 2025, and $314006.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Rein Therapeutics | 55.49 Mn | 55.49 Mn | - | 314,006.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 314,006.00 |
| Jun 30, 2026 | 314,006.00 |
| Mar 31, 2026 | 314,006.00 |
| Mar 31, 2026 | 314,006.00 |
| Dec 31, 2025 | 12,232.00 |
| Dec 31, 2025 | 12,232.00 |
| Sep 30, 2025 | 314,006.00 |
| Sep 30, 2025 | 314,006.00 |
| Jun 30, 2025 | 314,006.00 |
| Jun 30, 2025 | 314,006.00 |
| Mar 31, 2025 | 314,006.00 |
| Mar 31, 2025 | 314,006.00 |
| Dec 31, 2024 | 12,232.00 |
| Dec 31, 2024 | 12,232.00 |
| Sep 30, 2024 | 314,006.00 |
| Sep 30, 2024 | 314,006.00 |
| Jun 30, 2024 | 314,006.00 |
| Jun 30, 2024 | 314,006.00 |
| Mar 31, 2024 | 314,006.00 |
| Mar 31, 2024 | 314,006.00 |